If Astra Zenica think EsoBiotec is worth up to 1 Billion then we are worth 20 Billion.
EsoBiotec is only in 2 early phase 1 trails being conducted in one site in China. First patients dosed 27th January this year and 18th November 2024. Sure it's showing promise but it's very early stage and only in a few indications
Compare this to our products in multiple highly esteemed US and AUS hospitals, much further down the path to approval and if approved infinitely more commercial potential. We're going after all solid tumors, the entire market. If successful we have the cure for cancer. There is really no comparison.
This to me is highly encouraging. More likely scenario is the BOD were approached but told AZ to come back when they're serious.
IMU Price at posting:
3.4¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)